Why the study?
Do echocardiographic cardiac abnormalities in patients with classic rheumatoid arthritis persist and cause clinical complications over 4 years?
Do echocardiographic cardiac abnormalities in patients with classic rheumatoid arthritis persist and cause clinical complications over 4 years?
Echocardiographic cardiac abnormalities in rheumatoid arthritis patients frequently persist over 4 years but remain clinically insignificant without progression to heart failure or constrictive pericarditis.
Persistent echocardiographic changes in RA remain clinically silent at 4 years; supports conservative monitoring but leaves open need for larger prospective cohorts.
Initial studies from Bowman Gray School of Medicine showed that 18 of 30 patients with classic rheumatoid arthritis (RA) had cardiac involvement from their disease. These abnormalities were detected by echocardiography and consisted of mitral valve and/or pericardial abnormalities. All patients were followed for 4 years from the initial workup. Mitral valve abnormalities were seen on followup in 63% of the patients who initially showed this abnormality, while pericardial effusion remained in 20%. Pericardial thickening persisted in 6 of 7 patients. None of the patients developed constrictive pericarditis or heart failure. There was no definite correlation between persistence of these abnormalities and other clinical data, but it was noticed that patients who had persistent pericardial effusion and mitral valve abnormalities showed a higher number of involved joints and a higher erythrocyte sedimentation rate. The cardiac abnormalities described in this study have remained clinically insignificant in this population of RA patients.
No takes yet. Share an insight, caveat, or question.
Nomeir et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: